Poet Faces Legal Risk And Tax Questions But There Is Upside Potential

The post Poet Faces Legal Risk and Tax Questions but There is Upside Potential appeared first on 24/7 Wall St..

I’ll cut to the chase. POET Technologies (NASDAQ:POET) just lived through one of the more brutal weeks in small-cap semiconductors, and the wreckage has reset the setup.

Our 24/7 Wall St. price target for POET is $10.51 over the next 12 months, implying 59.28% upside from $6.60. Confidence sits at moderate, roughly 50%, reflecting genuine asymmetry against very real legal and dilution risk.

24/7 Wall St. Price Target Summary

The Lawsuit That Cracked the Rally

POET fell 17.81% on April 29 and 48.32% over the past week, yet remains up 62.16% over the past year and 29.92% over the past month.

The trigger was a Rosen Law Firm class action filed April 29 covering buyers between April 1 and April 27, 2026, alleging misleading statements about POET’s Passive Foreign Investment Company status. That followed an April 14 Wolfpack Research short report calling the story a stock promote with a tax problem.

Management has responded by committing to QEF election documentation and a redomicile to the United States, with a shareholder vote on June 26, 2026. Q4 2025 showed revenue of $341,202 and EPS of -$0.32, missing expectations, but POET ended the period with $430 million in cash.

Why Bulls See a Breakout to $17

The bull case rests on optical engine commercialization. POET secured a production order exceeding $5 million for optical engines and is targeting shipments of more than 30,000 optical engines in 2026. Strategic partnerships with LITEON Technology on next-gen AI data center modules and Lessengers on 1.6T 2xDR4 optical transceivers point at a real product roadmap into co-packaged optics for hyperscalers.

If those ramps land, our bull scenario points to $17.05, a 158.33% return. Simply Wall Street published a $17.37 fair value estimate, and the 52-week high of $15.50 shows the market has paid up before.

The Risks Worth Watching

The bear case is concrete. The Rosen class action overhangs the stock, and Wolfpack flagged a seventh business pivot, repeated dilution, and rich valuation at a price-to-sales ratio of 1140 on trailing revenue of $1,074,900.

Bulls would counter that POET is mid-pivot from R&D to volume manufacturing, that quarterly revenue growth was 10.75%, and that the $525 million raised since 2025 funds the optical engine ramp without near-term going-concern risk. Still, our bear scenario lands at $8.40, with the 52-week low of $3.87 as the worst-case anchor if the lawsuit drags into 2027.

I’d Buy the Dislocation, Carefully

My 24/7 Wall St. price target stays at $10.51 with a buy rating and moderate confidence. The single factor that tips the scale is cash. POET has the runway to ship product before the legal cycle resolves.

I’d be a buyer here if the June 26 redomicile vote passes and Q2 shipments confirm the 30,000-unit pace. I’d stay on the sidelines if dilution accelerates or the lawsuit expands beyond PFIC disclosures.

Looking further ahead, here is where our 24/7 Wall St. price target model projects POET could trade, assuming optical engine volumes scale and the U.S. redomicile resolves the PFIC overhang.

These projections track our base-case 5-year output of $23.54 by April 2031. Significant upside or downside could result from hyperscaler design wins or an adverse lawsuit settlement.

The post Poet Faces Legal Risk and Tax Questions but There is Upside Potential appeared first on 24/7 Wall St..